Business Insider

R2 Technologies's GLACIAL®Rx Clinical Data Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS)

SAN RAMON, Calif., May 3, 2022 /PRNewswire/ -- R2 Technologies Inc. ("R2"), the world leader in CryoAesthetic™ medical devices, today announced that data related to GLACIAL ® Rx, the first-to-market ...
Nasdaq

R2 Technologies Receives Expanded FDA Clearances, Launches Backbar Treatment Kit to Broaden Patient and Provider Reach, and Announces Allies of Skin Partnership

DUBLIN, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- R2 Technologies Inc. ("R2"), the world leader in CryoAesthetics™ technology and the creator of Glacial® Rx, the first-to-market in-office precision ...
Nasdaq

HC2 Holdings Portfolio Company R2 Technologies Disrupts the Aesthetics Industry with Launch of Its Groundbreaking Glacial Rx™ Treatment

NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2” or “the Company”) (NYSE: HCHC) today announced that its portfolio company R2 Technologies Inc. (“R2”) the leader in ...
Seeking Alpha

INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics ® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (VATE) ...
Seeking Alpha

INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation

Glacial Skin delivers controlled cooling to reduce inflammation, brighten skin, and correct pigment, all with zero downtime. In Q2 2025, patient treatments increased 115% and average monthly ...
KTLA

R2 Technologies Reports Record-Breaking Quarter and Announces 2023 ICY Award Winners

R2 achieved an extraordinary 111% year-over-year increase in system sales in North America from 2022 to 2023. Furthermore, the company experienced a 76% increase in sales from Q3 to Q4 alone, ...
Business Insider

Pansend Life Sciences' Portfolio Company, R2 Technologies, Receives Additional $10 Million Equity Investment From Huadong Medicine Company Limited

NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Technologies (“R2”), a privately-held portfolio company ...
WOOD-TV

R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands

R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems, has achieved several impressive milestones during 2024. Our Q2 and Q3 results are a testament to ...